Generation and characterization of E1/E2a/E3/E4-deficient adenoviral vectors encoding human factor VIII.
about
An adenovirus type 5 (Ad5) amplicon-based packaging cell line for production of high-capacity helper-independent deltaE1-E2-E3-E4 Ad5 vectors.Recent advances in genetic modification of adenovirus vectors for cancer treatmentAntitumor activity of an hTERT promoter-regulated tumor-selective oncolytic adenovirus in human hepatocellular carcinomaGene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects.Hyperactive sleeping beauty transposase enables persistent phenotypic correction in mice and a canine model for hemophilia B.Gene therapy progress and prospects: adenoviral vectors.Suppression of leaky expression of adenovirus genes by insertion of microRNA-targeted sequences in the replication-incompetent adenovirus vector genome.Persistent expression of factor VIII in vivo following nonprimate lentiviral gene transfer.Genetic engineering for haemophilia A.Engineering Factor Viii for Hemophilia Gene Therapy.Transient blockade of the inducible costimulator pathway generates long-term tolerance to factor VIII after nonviral gene transfer into hemophilia A miceNew insights on adenovirus as vaccine vectors.Immunomodulation for inhibitors in hemophilia A: the important role of Treg cellsViral hybrid vectors for somatic integration - are they the better solution?Destination Brain: the Past, Present, and Future of Therapeutic Gene Delivery.Anti-Inflammatory Effects of Modified Adenoviral Vectors for Gene Therapy: A View through Animal Models Tested.Prospects for the use of artificial chromosomes and minichromosome-like episomes in gene therapy.Advances in Overcoming Immune Responses following Hemophilia Gene Therapy.Persistent hepatic expression of human apo A-I after transfer with a helper-virus independent adenoviral vector.Bone marrow mesenchymal cells for haemophilia A gene therapy using retroviral vectors with modified long-terminal repeats.
P2860
Q27469506-EAFE45F1-7DEC-40E7-8C12-2FF956D56534Q33738828-8FB9C004-07B9-4ED7-9677-C8192A2C0FDAQ33868732-CFE9B323-7CE2-4D6B-B492-50E3222C5375Q33881920-174538B3-0A6C-41B3-9C03-8A4172CE8349Q34343757-2B9D4E03-2D62-4589-BE41-61BAECEF2630Q35165719-B47BFD67-B43B-458B-9BB7-BA2DB29D3B21Q35184207-6F6E7CD0-CA86-4A2C-9D76-D0D849CA9435Q35848097-E0E96ABD-ABB9-4059-8409-1A6A61D3EB45Q36600245-5A3356CD-F624-4A37-A5A1-4EAFCD0D62F0Q36737263-56CA297F-98AD-4081-AB83-A292E01E8177Q36843682-3B5BDF70-BFF0-4ECF-9580-F0E44FEF1895Q37513550-FA6E17F4-6E43-488C-9919-C0AADF7CD760Q37803130-AED2FDD7-EE8A-4848-B7C4-BC12EC57B651Q37945189-8EF05810-ABA8-4260-804C-40380ECA1FF4Q38761724-28F1AEB3-9B7A-454E-BB42-B0B809B11E02Q38849248-203DA545-34BC-4955-B166-18579CBCD30EQ41982319-BC96DF92-7E38-4BBC-9B8C-2D0BDC4252A2Q42209182-2D60C0FF-E86C-4D78-9E14-698BC250BCB6Q44198855-1077AABC-736B-4849-84F8-D33D1C917D75Q45858232-42648A82-8EE0-4C31-BC27-380143A4510C
P2860
Generation and characterization of E1/E2a/E3/E4-deficient adenoviral vectors encoding human factor VIII.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Generation and characterizatio ...... rs encoding human factor VIII.
@en
Generation and characterizatio ...... rs encoding human factor VIII.
@nl
type
label
Generation and characterizatio ...... rs encoding human factor VIII.
@en
Generation and characterizatio ...... rs encoding human factor VIII.
@nl
prefLabel
Generation and characterizatio ...... rs encoding human factor VIII.
@en
Generation and characterizatio ...... rs encoding human factor VIII.
@nl
P2093
P356
P1433
P1476
Generation and characterizatio ...... rs encoding human factor VIII.
@en
P2093
P304
P356
10.1006/MTHE.2001.0264
P577
2001-03-01T00:00:00Z